Stopping therapy safely in ulcerative colitis with no inflammation
Part of Digestive system clinical trials.
This trial tests whether people with ulcerative colitis who have been in deep remission (no signs of active disease) can safely reduce or stop their current medication. It aims to find out if careful monitoring can keep them healthy without full-dose treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old and have had ulcerative colitis for at least 3 years.
- Your last colonoscopy within the past year showed no signs of active inflammation (both inside the colon and under the microscope).
- You must be in remission without any symptoms, elevated inflammation markers, or recent changes in your therapy.
- You cannot have active inflammation, recent steroid use, or a history of certain liver or colon conditions.
- You must be able to follow the study's schedule for sample collection and check-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if older adults with ulcerative colitis who have been in remission for a long time can safely stop taking their immune-suppressing medication (thiopurine). It may help reduce medication side effects while keeping the disease under control.
This trial tests if patients with ulcerative colitis or Crohn's disease who are already stable on stronger medications (biologics or immunomodulators) can safely stop taking their 5-ASA (mesalamine) pill. It aims to see if stopping 5-ASA affects disease control.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This trial studies whether people with Crohn's disease or ulcerative colitis who are in deep remission can safely reduce their dose of ustekinumab (Stelara) without the disease coming back. It aims to reduce medication burden while keeping patients well.
This study tests whether using a simple stool test to guide treatment is better than usual care for people with ulcerative colitis in remission. It aims to keep you in remission longer and prevent flare-ups.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.